How It Works

Members get access to our research, price targets, and a real-time margin of safety for emerging synthetic biology and biotech stocks.

Better data for better returns.

Solt DB Invest shows you how much biotech stocks need to rise or fall in real time to reach our modeled price target. This is called the Margin of Safety.

By quantifying our research in a simple dashboard, it's available whenever you are.

A screenshot of Solt DB Invest's Margin of Safety Dashboard.

Invest with confidence.

We remove the guesswork and emotions from biotech investing. Solt DB Invest modeling independently predicts the attractiveness of biotech stocks as a whole.

For example, only two stocks we cover are in the top 50 holdings of the SDPR S&P Biotech ETF $XBI, but our overall coverage ecosystem often signals the highs and lows of $XBI to within a few days.

The predictive power of our overall coverage ecosystem is driven by accurate modeling of individual biotech businesses.

Insights into today's trends, down to the cell.

Solt DB uses the same illustration tools as scientists publishing in the world's top journals -- a first in finance.

The combination of simple language and clear visuals allows investors of all backgrounds to more deeply understand the biotech stocks they own, while scientists can gain a better grasp of the business of biotech.

An illustration showing differences in the lipid nanoparticles used for two drug candidates from Verve Therapeutics.

Make boring financials come alive.

We don't bury you with walls of text or regurgitate press releases. Our bottom-up approach combines technical competence with analytical rigor to simplify the challenges, opportunities, and bottlenecks facing businesses.

Click or hover this chart to view data labels.

Simplifying biotech for investors of all stripes -- or feathers.

Save
time with our real-time rankings
Trust
our domain expertise & unbiased research
Learn
in vivid detail with data visualizations

Deep tech requires deep analysis.

Seeing is believing.

We've opened our complete research on 10x Genomics $TXG and Relay Therapeutics $RLAY, so you can see our approach. No credit card, email address, or trial period required.
The logo for Relay Therapeutics.